Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 5/20 | 0.45 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.38 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | TDO2 | P48775 | 1/20 | 0.34 |
| ▸ | F9 | P00740 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.33 |
| ▸ | GABRP | O00591 | 1/20 | 0.33 |
| ▸ | GABRD | O14764 | 1/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17382929 | 0.92 | CYP1A1 (0.46) | CYP1A1CYP1B1CYP1A2LIMK1ALOX5 | |
| SCHEMBL17382925 | 0.92 | CYP1A1 (0.45) | CYP1A1CYP1B1CYP1A2LIMK1ALOX5 | |
| SCHEMBL22688528 | 0.89 | ALOX5 (0.43) | CYP1A1CYP1B1CYP1A2BIRC5LIMK1 | |
| SCHEMBL22688184 | 0.89 | CYP1A1 (0.47) | CYP1A1CYP1B1CYP1A2BIRC5LIMK1 | |
| SCHEMBL22789798 | 0.89 | CYP1A1 (0.49) | CYP1A1CYP1B1CYP1A2LIMK1ALOX5 | |
| SCHEMBL22688539 | 0.88 | ALOX5 (0.42) | CYP1A1CYP1B1CYP1A2BIRC5MAOA | |
| SCHEMBL15893273 | 0.87 | CYP1A1 (0.48) | CYP1A1CYP1B1CYP1A2LIMK1ALOX5 | |
| SCHEMBL17382960 | 0.87 | CYP1A1 (0.41) | CYP1A1CYP1B1CYP1A2LIMK1MAOB | |
| SCHEMBL17382939 | 0.87 | CYP1A1 (0.41) | CYP1A1CYP1B1CYP1A2LIMK1MAOB | |
| SCHEMBL29344301 | 0.87 | CYP1B1 (0.47) | CYP1A1CYP1B1CYP1A2LIMK1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11713291-B2 | Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-08-01 | — | — | US | disclosed |
| US-11713291-B2 | Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-08-01 | — | — | US | disclosed |
| WO-2020130394-A1 | ORGANIC ELECTRIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR | 덕산네오룩스 주식회사 | 2020-06-25 | — | — | WO | disclosed |
| EP-3670510-A2 | BENZO[B]NAPHTHO[2,3-D]FURANYL- OR BENZO[B]NAPHTHO[2,3-D]THIOPHENYL-TRIAZINE COMPOUNDS FOR ORGANIC ELECTRONIC ELEMENTS | Duk San Neolux Co., Ltd. (KR) | 2020-06-24 | — | — | EP | disclosed |
| WO-2017200320-A1 | COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF | 덕산네오룩스 주식회사 | 2017-11-23 | — | — | WO | disclosed |
| WO-2017191976-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2017-11-09 | — | — | WO | disclosed |
| US-20170317290-A1 | ORGANIC ELECTRONIC DEVICE AND DISPLAY APPARATUS USING COMPOSITION FOR ORGANIC ELECTRONIC DEVICE | DUK SAN NEOLUX CO., LTD. (KR) | 2017-11-02 | — | — | US | disclosed |
| US-20170317290-A1 | ORGANIC ELECTRONIC DEVICE AND DISPLAY APPARATUS USING COMPOSITION FOR ORGANIC ELECTRONIC DEVICE | DUK SAN NEOLUX CO., LTD. (KR) | 2017-11-02 | — | — | US | disclosed |
| WO-2017188655-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT | 덕산네오룩스 주식회사 | 2017-11-02 | — | — | WO | disclosed |
| US-20170317289-A1 | ORGANIC ELECTRONIC DEVICE AND DISPLAY APPARATUS USING COMPOSITION FOR ORGANIC ELECTRONIC DEVICE | DUK SAN NEOLUX CO., LTD. (KR) | 2017-11-02 | — | — | US | disclosed |
| US-20170317289-A1 | ORGANIC ELECTRONIC DEVICE AND DISPLAY APPARATUS USING COMPOSITION FOR ORGANIC ELECTRONIC DEVICE | DUK SAN NEOLUX CO., LTD. (KR) | 2017-11-02 | — | — | US | disclosed |
| WO-2016072690-A1 | ORGANIC ELECTRONIC DEVICE AND DISPLAY DEVICE USING COMPOSITION FOR ORGANIC ELECTRONIC DEVICE | 덕산네오룩스 주식회사 | 2016-05-12 | — | — | WO | disclosed |
| WO-2016072691-A1 | ORGANIC ELECTRONIC DEVICE AND DISPLAY DEVICE USING COMPOSITION FOR ORGANIC ELECTRONIC DEVICE | 덕산네오룩스 주식회사 | 2016-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11713291-B2 | Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof | PIEZO1, ORAI2, EXOC1 | CYP1A1 3143/4885CYP1B1 3834/4885CYP1A2 2514/4885 |
| US-20170317289-A1 | ORGANIC ELECTRONIC DEVICE AND DISPLAY APPARATUS USING COMPOSITION FOR ORGANIC ELECTRONIC DEVICE | OCIAD2, OCIAD1, EPHA4 | CYP1A1 1980/4885CYP1B1 2957/4885CYP1A2 2484/4885 |
| US-20170317290-A1 | ORGANIC ELECTRONIC DEVICE AND DISPLAY APPARATUS USING COMPOSITION FOR ORGANIC ELECTRONIC DEVICE | OCIAD2, OCIAD1, EPHA4 | CYP1A1 1980/4885CYP1B1 2957/4885CYP1A2 2484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.